HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M200006-JLR200v1 44/2/430    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tilly, P. Articles by Visvikis, S. Search for Related Content PubMed PubMed Citation Articles by Tilly, P. Articles by Visvikis, S. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 44, 430-436, February 2003
Copyright © 2003 by Lipid Research, Inc.

Biological and genetic determinants of serum apoC-III concentration

Peggy Tilly, Catherine Sass, Monique Vincent-Viry, Dominique Aguillon, Gérard Siest¹ and Sophie Visvikis

Institut National de Santé et de Recherche Médicale U525, Centre de Médecine Préventive, 2 Avenue du Doyen J. Parisot, F54500 Vandoeuvre-Lès-Nancy, France

¹ To whom correspondence should be addressed. e-mail: gerard.siest{at}cmp.u-nancy.fr

Apolipoprotein C-III (apoC-III) is involved in triglycerides metabolism, and is therefore important for the pathogenesis of coronary heart diseases. However, to our knowledge serum apoC-III variation factors and reference limits have never been determined, so the aim of this study was to establish them and facilitate clinical usefulness. We measured serum apoC-III concentration of apparently healthy subjects of the Stanislas Cohort by an immunoturbidimetric method. Genetic polymorphisms within the APOC3, APOE, APOAIV, and LPL genes were determined by a multiplex PCR. Serum apoC-III concentration varied from 28.2 mg/l to 225.8 mg/l in the overall sample and between subjects variability was about 30%. Factors influencing apoC-III concentration were age, BMI in adult men, alcohol consumption in adults, oral contraceptive intake in women, the post-pubescent status in boys.

The APOC3 1100T allele in adult men and the APOC3 -455C allele in boys were associated with increased apoC-III concentration. The APOA4 360His allele was associated with decreased apoC-III concentration in women. We also established reference limits of serum apoC-III concentration according to age and gender.

Supplementary key words apolipoproteins • lipids • reference values • polymorphism

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. A Ruiz-Narvaez, F. M Sacks, and H. Campos Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction, Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1932 - 1938. [Abstract] [Full Text] [PDF]

				R. Femia, A. Natali, A. L'Abbate, and E. Ferrannini Coronary Atherosclerosis and Alcohol Consumption: Angiographic and Mortality Data Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1607 - 1612. [Abstract] [Full Text] [PDF]

				O. Olivieri, N. Martinelli, M. Sandri, A. Bassi, P. Guarini, E. Trabetti, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, et al. Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and "Insulin-Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction Clin. Chem., February 1, 2005; 51(2): 360 - 367. [Abstract] [Full Text] [PDF]

				O. Olivieri, A. Bassi, C. Stranieri, E. Trabetti, N. Martinelli, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, and R. Corrocher Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease J. Lipid Res., December 1, 2003; 44(12): 2374 - 2381. [Abstract] [Full Text] [PDF]